Form4insider filings, from the source

SEC Form 4 · accession 0001609351-19-000029

Spark Therapeutics, Inc. · ONCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Federico Mingozzi
Officer — Chief Scientific Officer
Period of report
Jun 26, 2018
Accepted (ET)
Jan 23, 2019 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 26, 2018M8,375—A8,375D
Common StockJun 26, 2018F2,627$87.98D5,748D
Common StockF1Jan 18, 2019M2,000—A7,748D
Common StockJan 18, 2019F733$45.08D7,015D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF2,F3—Jun 26, 2018M8,375D——Common Stock8,37525,125D
Restricted Stock UnitsF2,F4—Jan 18, 2019M2,000D——Common Stock2,0006,000D

Explanation of responses